Digital Diabetes Management Market, By Product (Device (Smart Glucometer, CGM, Insulin Pump & Patch), Diabetes Apps, Service, Data Management Software), Device Type (Hand-held & Wearables), End User (Hospitals & Self/home healthcare) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The global Digital Diabetes Management Market is anticipated to reach USD 10.1 billion in 2021 growing at a CAGR of 27.5% during the forecasting period, 2021-2028.
Diabetes is a metabolic disorder where the body is unable to produce enough insulin. It can’t be cured but can be managed. AI along with multiple digital research and medicine are used for the management of diabetes. The technology of glucometer helps the patient to take note of its blood sugar level anytime. The Dexcom G6 is the latest developed CGM or continuous glucose monitor.
With a surge in cases of diabetes along with increased use of technology for its management are some of the factors that have supported long-term expansion for the digital diabetes management industry.
The global Digital Diabetes Management Market is segmented into Product, Device Type, End-User, and geography.
The product segment is segmented into Device, Diabetes Apps, Service, and Data Management Software
The device type segment is segmented into Hand-held & Wearables
The end-user segment is segmented into Hospitals & Self/home healthcare
Geographically, the global Digital Diabetes Management Market is sub-segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America and insights are provided for each region and major countries within the regions
Key players in the global Digital Diabetes Management Market are Medtronic (Ireland), B. Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care (Switzerland), LifeScan (US), Tidepool (US), AgaMatrix (US), Glooko Inc. (US), and DarioHealth (Israel) among others.
Report Feature |
Descriptions |
---|---|
Market Revenue In 2021 |
USD 10.1 billion |
Growth Rate |
CAGR of 27.5% during the forecasting period, 2021-2028 |
Historical Data |
2018-2019 |
Forecast Years |
2021-2028 |
Base Year |
2020 |
Units Considered |
Revenue in USD billion and CAGR from 2021 to 2028 |
Report Segmentation |
Product, Device Type, End User and Geography |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Medtronic (Ireland), B. Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care (Switzerland), LifeScan (US), Tidepool (US), AgaMatrix (US), Glooko Inc. (US), and DarioHealth (Israel) |
Available Customization |
In addition to the market data for Global Digital Diabetes Management Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |